1. Zhou, Chenfei, Feng, Xiaojing, Yuan, Fei, Zhu, Zhenggang, Zhang, Jun. 2018. Difference of molecular alterations in HER2-positive and HER2-negative gastric cancers by whole-genome sequencing analysis. In Cancer management and research, 10, 3945-3954. doi:10.2147/CMAR.S172710. https://pubmed.ncbi.nlm.nih.gov/30310315/
2. Ding, Yang, Liu, Pengfei, Zhang, Shengsheng, Tao, Lin, Han, Jianmin. 2018. Screening pathogenic genes in oral squamous cell carcinoma based on the mRNA expression microarray data. In International journal of molecular medicine, 41, 3597-3603. doi:10.3892/ijmm.2018.3514. https://pubmed.ncbi.nlm.nih.gov/29512771/
3. Takahashi, Takamasa, Matsuda, Yasunori, Yamashita, Satoshi, Nagino, Masato, Ushijima, Toshikazu. 2013. Estimation of the fraction of cancer cells in a tumor DNA sample using DNA methylation. In PloS one, 8, e82302. doi:10.1371/journal.pone.0082302. https://pubmed.ncbi.nlm.nih.gov/24312652/
4. Li, Mu-Xing, Wang, Hang-Yan, Yuan, Chun-Hui, Zhang, Li, Xiu, Dian-Rong. 2021. Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer. In Frontiers in oncology, 11, 619517. doi:10.3389/fonc.2021.619517. https://pubmed.ncbi.nlm.nih.gov/33747931/
5. Zhou, Zhen, Liu, Zichuan, Ou, Qiuxiang, Liu, Hongyan, Yang, Yu. 2021. Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases. In Cancer biology & medicine, 18, 490-501. doi:10.20892/j.issn.2095-3941.2020.0120. https://pubmed.ncbi.nlm.nih.gov/33710807/
6. Chen, Yan, Yin, Dong, Li, Lei, Deng, Yan-Chao, Tian, Wei. 2014. Screening aberrant methylation profile in esophageal squamous cell carcinoma for Kazakhs in Xinjiang area of China. In Molecular biology reports, 42, 457-64. doi:10.1007/s11033-014-3788-z. https://pubmed.ncbi.nlm.nih.gov/25304811/
智鼠故事 
